Metoprolol Succinate Clinical Trials
4 recruitingDrug
Phase 42Phase 32
Showing 1–4 of 4 trials
Recruiting
Phase 4
Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol in Heart Failure With Reduced Ejection Fraction Patients With Low vs. High Polygenic Score
Heart Failure With Reduced Ejection Fraction
University of Michigan100 enrolled1 locationNCT07490067
Recruiting
Phase 3
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
End Stage Renal DiseaseEnd-stage Kidney Disease
VA Office of Research and Development2,540 enrolled8 locationsNCT05931276
Recruiting
Phase 4
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
CardiomyopathySudden Cardiac DeathHeart Failure With Reduced Ejection Fraction (HFrEF)+3 more
University of Rochester2,000 enrolled13 locationsNCT06964464
Recruiting
Phase 3
The Efficacy and Safety of Metoprolol as add-on Treatment to Standard of Care in Preventing Cardiomyopathy in Patients With DMD
Muscular Dystrophy, Duchenne
Medical University of Gdansk150 enrolled1 locationNCT05066633